Takeru Funakoshi

17PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 02, 2026
Pathologic deep margin distance and prognosis in invasive acral melanoma of the sole.

|Mar 04, 2026
Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Yoshio Nakamura, Naoya Yamazaki, Kenjiro Namikawa

|Apr 04, 2025
Adjuvant Anti-PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients.

Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki

|Jun 01, 2024
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).

Ikuko Hirai, Keiji Tanese, Yoshio Nakamura

|Jan 29, 2024
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial.

Takuya Maeda, Teruki Yanagi, Keiko Tokuchi

|Apr 25, 2022
Management and outcomes of hydronephrosis in patients with metastatic extramammary Paget's disease: A retrospective analysis.

Takayuki Fusumae, Keitaro Fukuda, Ikuko Hirai

Pageof 3

Frequent Collaborators

4 joint publications

Yuki Yamamoto

4 joint publications

Shigeto Matsushita

3 joint publications

Eiji Nakano

3 joint publications

Takuya Miyagawa